Effectiveness of combination therapy with a sulfonylurea and once-daily insulin glargine in Japanese type 2 diabetic patients -Evaluation of the long-term (18 months) results of the combination therapy-

Journal of the Japan Diabetes Society

Volumn 50, Issue 8, 2007, Pages 591-597

  Goto, Hiromasa ^a   Hirose, Takahisa ^a   Shimizu, Tomoaki ^a   Mita, Tomoya ^a   Igarashi, Yasuhiro ^a   Fujitani, Yoshio ^a   Tanaka, Yasushi ^a,b   Watada, Hirotaka ^a   Kawamori, Ryuzo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35348905429     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. UK Prospective Diabetes study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS33). Lancet 352: 837-853
2. Binder C, Lauritzen T, Faber O and Pramming S (1984) Insulin pharmacokinetics. Diabetes Care 7: 188-199
3. Henemann L, Richter B (1993) Clinical pharmacology of human insulin. Diabetes Care 16 (suppl. 3): 90-100
4. Yki-Jarvinen H, Dressler A, Ziemen M. The HOE 901/3002 Study Group (2000) Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23: 1130-1136
5. Japanese source
6. Japanese source
7. Japanese source
8. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 239: 977-986
9. Ohkubo Y, Kishikawa H, Araki E, Miyata T. Isami S, Motoyoshi S, Kojima Y, Furoyoshi N, Shichiri M (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117
10. Japanese source
11. Yoshihara T, Kumashiro N, Kanazawa Y, Mita T, Sakurai Y, Kawai J, Abe M, Motojima K, Hara K, Yamazaki K, Kanazawa A, Miwa S, Sato F, Kanno R, Shimizu T, Sakai K, Uchino H, Watada H, Tanaka Y, Kawamori R, Hirose T. (2006) Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus. Endocr J 53: 67-72
12. Kumashiro N, Yoshihara T, Kanazawa Y, Shimizu T, Watada H, Tanaka Y, Fujitani Y, Kawamori R, Hirose T (2007) Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study. Endocr J 54:163-166